Search

everythinglearnresearchcommunity

for

Search:↓

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

PRAME helps distinguish between benign and malignant skin cells in most cases.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Platinum compounds used in cancer treatment can cause serious side effects like organ damage and hair loss.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

The compounds tested could potentially treat hair loss and alopecia.

Blood pressure medications may increase the risk of skin cancer.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Ionizing radiation damages human hair follicles by stopping cell growth, causing cell death, disrupting color, and increasing stress and damage markers.

Propylthiouracil treatment can cause hair loss.